New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
November 19, 2009
07:15 EDTCELG
theflyonthewall.com: Celgene earnings and sales growth guidance achievable, says Citigroup
Citigroup believes investors are concerned that Celgene's 2009-2012 sales and earnings growth guidance is not achievable. However, after reviewing its estimates, Citi believes the guidance can be met through Revlimid's global expansion, treatment duration increase and price increases. The firm keeps a Buy rating on the stock. :theflyonthewall.com



News For CELG From The Last 14 Days
Check below for free stories on CELG the last two weeks.
There are 8 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 10, 2012
10:01 EDTCELG
theflyonthewall.com: On The Fly: Analyst Initiation Summary

Subscribe for More Information
:theflyonthewall.com
06:36 EDTCELG
theflyonthewall.com: Celgene initiated with an Overweight at Morgan Stanley

Subscribe for More Information
:theflyonthewall.com

February 9, 2012
08:10 EDTCELG
theflyonthewall.com: Celgene makes $15M strategic equity investment in Acetylon

Subscribe for More Information
:theflyonthewall.com

February 6, 2012
13:00 EDTCELG
theflyonthewall.com: Celgene, Sloan-Kettering head accused in federal lawsuit, Bloomberg reports

Subscribe for More Information
:theflyonthewall.com

January 31, 2012
11:21 EDTCELG
theflyonthewall.com: Piper Jaffray's biotech and specialty pharma analysts hold a conference call

Subscribe for More Information
:theflyonthewall.com

January 27, 2012
08:38 EDTCELG
theflyonthewall.com: Celgene price target raised to $95 from $89 at Summer Street

Subscribe for More Information
:theflyonthewall.com
08:08 EDTCELG
theflyonthewall.com: Celgene remains a top pick for 2012 at Piper Jaffray

Subscribe for More Information
:theflyonthewall.com
07:31 EDTCELG
theflyonthewall.com: Celgene downgraded to Hold from Buy at Argus

Subscribe for More Information
:theflyonthewall.com